← Open Payments lookup

JENNIFER FIGUEROA: Open Payments

NPI 1720239585 · NEW BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$303 in 17 payments from 8 companies in 2025. Trend: 2023 $222 · 2024 $498 · 2025 $303

Food & beverage: $303
CompanyPaymentsAmount
Janssen Biotech, Inc.6$114
ABBVIE INC.5$84
Aimmune Therapeutics, Inc.1$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$18
E.R. Squibb & Sons, L.L.C.1$18
Takeda Pharmaceuticals U.S.A., Inc.1$18
Celgene Corporation1$17
Braintree Laboratories, Inc.1$14

Products named: TREMFYA, IMBRUVICA, VOWST, EMBLAVEO, XIFAXAN, OPDIVO, ENTYVIO, REBLOZYL.

Industry payments across NJ — which companies pay providers there.